LONZA GRP AG/ADR (OTCMKTS:LZAGY) will release its earnings data on Wednesday, July 24th.

Shares of LONZA GRP AG/ADR stock opened at $34.76 on Tuesday. The firm’s fifty day moving average is $33.29. The stock has a market cap of $25.56 billion, a P/E ratio of 29.21, a P/E/G ratio of 2.26 and a beta of 1.13. LONZA GRP AG/ADR has a 12-month low of $24.70 and a 12-month high of $34.85.

Separately, Zacks Investment Research raised shares of Booz Allen Hamilton from a “hold” rating to a “buy” rating and set a $71.00 price objective on the stock in a research report on Friday, June 28th.


Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma&Biotech and Specialty Ingredients. Its products and services cover bio research solutions, such as stem cells primary cells and media, cell culture, transfection, exosomes, and assay solutions; electrophoresis of nucleic acids and proteins; primary and stem cell protocols; Hepatocytes/ADMETox solutions for microsomes and primary cell culture applications; and CytoSMART system, a live cell imaging and monitoring system.

Read More: Asset Allocation

Receive News & Ratings for LONZA GRP AG/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LONZA GRP AG/ADR and related companies with MarketBeat.com's FREE daily email newsletter.